Purple Biotech Ltd ADR (PPBT) concluded trading on Wednesday at a closing price of $2.40, with 4.44 million shares of worth about $10.66 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.46% during that period and on April 30, 2025 the price saw a loss of about -5.16%. Currently the company’s common shares owned by public are about 2.65M shares, out of which, 2.63M shares are available for trading.
Stock saw a price change of -10.19% in past 5 days and over the past one month there was a price change of -9.77%. Year-to-date (YTD), PPBT shares are showing a performance of -48.83% which decreased to -75.51% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.00 but also hit the highest price of $20.60 during that period. The average intraday trading volume for Purple Biotech Ltd ADR shares is 25.62K. The stock is currently trading -7.44% below its 20-day simple moving average (SMA20), while that difference is down -12.39% for SMA50 and it goes to -47.17% lower than SMA200.
Purple Biotech Ltd ADR (NASDAQ: PPBT) currently have 2.65M outstanding shares and institutions hold larger chunk of about 2.40% of that.
The stock has a current market capitalization of $6.36M and its 3Y-monthly beta is at 0.55. It has posted earnings per share of -$5.18 in the same period. It has Quick Ratio of 2.23 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PPBT, volatility over the week remained 12.93% while standing at 9.12% over the month.
